SELLAS Life Sciences
SLS
SLS
28 hedge funds and large institutions have $4.42M invested in SELLAS Life Sciences in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.86% less ownership
Funds ownership: 14.51% → 10.65% (-3.9%)
33% less capital invested
Capital invested by funds: $6.64M → $4.42M (-$2.22M)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Holders
28
Holding in Top 10
1
Calls
$1.37M
Puts
$141K
Top Buyers
| 1 | +$141K | |
| 2 | +$64.8K | |
| 3 | +$50K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$33K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$26.4K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$566K | |
| 3 | -$76.9K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$54K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$23K |